SCHEMBL6414161

SCHEMBL6414161

CCCc1cc(OC(=O)CCCC(=O)NCC2(SN=O)CCCCC2)c(C)cc1OCCN(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2D6 P10635 1/20 0.35
PKM P14618 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ADRA1D P25100 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
ADRA1B P35368 1/20 0.35
DRD3 P35462 1/20 0.35
OPRK1 P41145 1/20 0.35
CHRNA4 P43681 1/20 0.35
HIF1A Q16665 1/20 0.35
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC6A5 Q9Y345 5/20 0.33
THRB P10828 5/20 0.33
THRA P10827 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4697798 0.99 BLM (0.36) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL6414156 0.88 CYP1A2 (0.51) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4696143 0.87 CYP1A2 (0.38) CYP1A2ADRA2ACYP2D6PKMADRA2B
Hydrochloric Acid SCHEMBL4697785 0.87 BLM (0.52) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4692851 0.81 CYP1A2 (0.38) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL6416957 0.77 CYP1A2 (0.47) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4753904 0.76 CYP1A2 (0.36) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4696140 0.74 ADRA1D (0.54) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4696149 0.74 CYP1A2 (0.38) CYP1A2ADRA2ACYP2D6PKMADRA2B
SCHEMBL4694686 0.73 CYP1A2 (0.35) CYP1A2ADRA2ACYP2D6PKMADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469065-B1 COMPOUND THAT DONATES, TRANSFERS OR RELEASES NITRIC OXIDE, ELEVATES ENDOGENOUS LEVELS OF NITRIC OXIDE NITROMED, INC. 2002-10-22 US claimed
US-20050187222-A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds NITROMED, INC. (US) 2005-08-25 US disclosed
US-6469065-B1 COMPOUND THAT DONATES, TRANSFERS OR RELEASES NITRIC OXIDE, ELEVATES ENDOGENOUS LEVELS OF NITRIC OXIDE NITROMED, INC. 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187222-A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds ADRB1, ADRB3, ADRA1D CYP1A2 284/4885ADRA2A 11/4885CYP2D6 345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.